Irene Kim, PhD
About Irene Kim, PhD
Irene Kim, PhD, is the Executive Director and Chief of Staff to the EVP and Chief Research Officer at Bristol Myers Squibb, with a strong background in virology, oncology, and neuroscience.
Company
Irene Kim, PhD, currently serves as the Executive Director and Chief of Staff to the EVP and Chief Research Officer at Bristol Myers Squibb. She also holds the position of Senior Director in Research & Early Development, Portfolio Strategy and Integration at the same company. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.
Title
Irene Kim, PhD, is the Executive Director and Chief of Staff to the EVP and Chief Research Officer at Bristol Myers Squibb. In addition, she holds the role of Senior Director in Research & Early Development, Portfolio Strategy and Integration.
Education and Expertise
Irene Kim, PhD, earned her Ph.D. in Virology from Harvard University, where she also completed her undergraduate degree with an A.B. in Biochemical Sciences. Dr. Kim's scientific expertise spans multiple modalities, including cell therapies, antibody-drug conjugates (ADCs), cancer vaccines, and mRNA. Her research expertise covers fields such as oncology, virology, and neuroscience.
Background
Irene Kim, PhD, has a diverse background with experience in academia, management consulting, and the biotech and pharmaceutical industries. She worked as a Postdoctoral Researcher in Neuroscience at Caltech from 2013 to 2016. She later joined Boston Consulting Group (BCG) as a Project Leader from 2017 to 2019. Dr. Kim then transitioned to BioNTech SE, where she served as Director of Corporate/Business Development and Strategy from 2019 to 2021 in Cambridge, Massachusetts. Prior to her current roles at Bristol Myers Squibb, she was Director of Worldwide Commercialization, Strategy, and Innovation from 2021 to 2022.
Achievements
Throughout her career, Irene Kim, PhD, has demonstrated a strong track record in developing and operationalizing strategies and innovations across R&D, commercialization, and corporate strategy. She has experience building high-performing cross-functional teams and shows a strong commitment to mentorship and diversity & inclusion. Her work has spanned management consulting and roles in both biotech and large pharma companies, reflecting her broad expertise and impact in the industry.